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coronary surgical patients. Many centers nationally have partici-
pated in rehabilitating postoperative patients, perhaps with better 
results than the authors discuss in their report. Too many studies 
of postoperative patients (as well as postmyocardial infarction pa-
tients) with coronary artery disease do not adequately assess the 
role of risk factor modification, particularly the use of exercise in 
cardiac rehabilitation. 
gone surgery and have been followed up for 10 postoperative years. 
Not all patients in such a group will be able to submit to the 
consistent long-term monitoring required to document compliance 
to cardiac rehabilitation programs. The difficulty involved in study-
ing the influence of cardiac rehabilitation on long-term prognosis 
is not unique to our institution. Although it may be that "many 
centers nationally have participated in rehabilitating postoperative 
patients," few data are available. 
ELIHU YORK, MD, FACC 
Hartford Hospital 
Hartford, Connecticut 06115 
Reference 
It is our opinion that both risk factor modification and exercise 
rehabilitation are indicated in postoperative patients. Elimination 
of tobacco use, dietary counseling and an exercise program are 
all integral parts of our approach to the postoperative patient at 
The Cleveland Clinic Foundation. However, it is important to 
separate opinion and fact, and the facts are that neither risk factor 
modification nor exercise rehabilitation has been documented to 
influence the survival or event-free survival of postoperative patients. 
I. Lytle BW. Kramer JR, Golding LR, et al. Young adults with coronary athero-
sclerosis: 10 year results of surgical myocardial revascularization. J Am Call 
Cardiol 1984;4:445-53. 
Reply 
It is just not possible to accurately assess the impact of risk factor 
modification on a consecutive series of patients who have under-
,BRUCE W. LYTLE, MD, FACC 
The Cleveland Clinic Foundation 
Department of Cardiothoracic Surgery 
9500 Euclid Avenue 
Cleveland, Ohio 44106 
Correction 
Owing to an error by the compositor, the last paragraph on 
page 1160 of the article by the IMPACT Research Group 
entitled "International Mexiletine and Placebo Antiar-
ryhthmic Coronary Trial: I. Report on Arrhythmia and Other 
Findings" (J Am Coll Cardiol 1984;4: 1148-63) was in-
correctly printed. The correct version of the paragraph ap-
pears below. 
Conclusions. IMPACT as well as other studies have 
demonstrated the antiarrhythmic efficacy of mexiletine, but 
the mortality findings suggest that the suppression of ven-
tricular premature complexes and arrhythmias in patients 
after myocardial infarction may not result in a reduced mor-
tality rate. This is in contrast to treatment with beta-receptor 
blocking agents, where an antiarrhythmic effect may be one 
of the goals. IMPACT did not address the question of whether 
patients with specific types of arrhythmia may benefit from 
treatment that suppresses arrhythmia. The results of 
IMPACT as well as other studies raise questions concerning 
the hypothesis that control of arrhythmia will result in in-
creased survival for the majority of patients with myocardial 
infarction. 
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